Prime Medicine earnings were -$202.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PRME earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$51.9M, up 22.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRME reported annual earnings of -$195.9M, with -1.1% growth. The next PRME earnings date is Aug 6, 2025.
Prime Medicine (NASDAQ: PRME) reported Q1 2025 earnings per share (EPS) of -$0.40, up 9.09% year over year. Total PRME earnings for the quarter were -$51.89 million. In the same quarter last year, Prime Medicine's earnings per share (EPS) was -$0.44.
The next PRME earnings call is Invalid Date. Add PRME to your watchlist to be reminded of Prime Medicine's next earnings date.
Is Prime Medicine profitable or losing money?
As of the last Prime Medicine earnings report, Prime Medicine is currently losing money. Prime Medicine's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$202.01 million, a 1.22% decrease year over year.
What was PRME's earnings growth in the past year?
As of Prime Medicine's earnings date in Q3 2025, Prime Medicine's earnings has grown year over year. PRME earnings in the past year totalled -$202.01 million.
What are Prime Medicine's earnings expectations?
The current EPS estimate for Prime Medicine's earnings report in Invalid Date is -$0.43.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.